Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Man names John Rohal as Executive Chairman, North America

Wednesday, December 05, 2012
Opalesque Industry Update: Man Group plc, the global alternative investment manager, has hired John Rohal as Executive Chairman of Man, North America. John will work with Man’s fund managers to enhance Man’s range of offerings for the US. Reporting to Manny Roman, President and COO of Man, John will also work closely with Eric Burl and Lance Donenberg, respectively COO and Head of Sales for North America, to deepen Man’s relationships with institutions, foundations, family offices, intermediaries and other key client constituencies.

“John is a veteran of our industry whose expertise will help drive the business forward in a region where Man’s range of investment capabilities brings tremendous value to clients. As a seasoned investor and allocator who has also been an institutional client of the firm, John is exceptionally well-placed to work with institutional investors in the US to better understand their needs and deliver the appropriate investment management solutions," said Peter Clarke, Man CEO.

“I am delighted to be joining Man. I have had a long professional relationship with the firm and its people and it is an exciting challenge to come on board and help take the business forward here in North America. Man is a unique organization combining scale, breadth of products and global reach with headquarters in London and people located in major financial markets around the world. Further exposing North American investors to these capabilities will be part of a long term relationship-building process," said John Rohal.

John will start on January 1. At year end, he will be stepping down from his position as a member of the Investment Committee at the California-based Makena Capital Management, a leading independent global multi-asset class investment manager, where he is currently responsible for overseeing Makena's global investments in Public Equity and Tactical Hedged Equity. Previously he worked at Robertson Stephens, where he built the research department from 13 senior analysts to 45, covering all major growth industries. Prior to that he spent a decade at Alex Brown & Sons, where he was Managing Director and Co-Head of the Technology Research Group. Before entering financial services, John spent 14 years in leadership positions at industrial companies: Honeywell, Pfizer, Martin Marietta and IBM. He holds a BS from West Virginia University and an MBA from Wharton School of Finance.

Man Group

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its